Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James O. Kahn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Infectious Disease Reports|January 22, 2004
Primary HIV InfectionC. Bradley Hare, James O. Kahn
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Development of WF10, a novel macrophage-regulating agentMichael S McGrath, James O Kahn, Brian G Herndier
AIDS (London, England)|December 4, 2004
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAARTBeatriz Martinez-Mariño, Steve Shiboski, Frederick M Hecht, et al.
Archives of Internal Medicine|January 14, 2004
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virusSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS (London, England)|December 4, 2004
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United StatesSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletionRonnie L Gascon, Amy B Narváez, Rongzhen Zhang, et al.
AIDS (London, England)|May 11, 2002
Use of laboratory tests and clinical symptoms for identification of primary HIV infectionFrederick M Hecht, Michael P Busch, Bhupat Rawal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2012
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health settingElvin H Geng, C Bradley Hare, James O Kahn, et al.
JAMA|July 4, 2002
Time trends in primary HIV-1 drug resistance among recently infected personsRobert M Grant, Frederick M Hecht, Maria Warmerdam, et al.
The Journal of Infectious Diseases|July 10, 2004
HIV RNA testing in the context of nonoccupational postexposure prophylaxisMichelle E Roland, Tarek A Elbeik, James O Kahn, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Infectious Disease Reports|January 22, 2004
Primary HIV InfectionC. Bradley Hare, James O. Kahn
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Development of WF10, a novel macrophage-regulating agentMichael S McGrath, James O Kahn, Brian G Herndier
AIDS (London, England)|December 4, 2004
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAARTBeatriz Martinez-Mariño, Steve Shiboski, Frederick M Hecht, et al.
Archives of Internal Medicine|January 14, 2004
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virusSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
AIDS (London, England)|December 4, 2004
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United StatesSteven D Pinkerton, Jeffrey N Martin, Michelle E Roland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletionRonnie L Gascon, Amy B Narváez, Rongzhen Zhang, et al.
AIDS (London, England)|May 11, 2002
Use of laboratory tests and clinical symptoms for identification of primary HIV infectionFrederick M Hecht, Michael P Busch, Bhupat Rawal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2012
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health settingElvin H Geng, C Bradley Hare, James O Kahn, et al.
JAMA|July 4, 2002
Time trends in primary HIV-1 drug resistance among recently infected personsRobert M Grant, Frederick M Hecht, Maria Warmerdam, et al.
The Journal of Infectious Diseases|July 10, 2004
HIV RNA testing in the context of nonoccupational postexposure prophylaxisMichelle E Roland, Tarek A Elbeik, James O Kahn, et al.
Pageof 2